表紙:ヘルスケア分析市場 - 予測(2021年~2026年)
市場調査レポート
商品コード
1023162

ヘルスケア分析市場 - 予測(2021年~2026年)

Healthcare Analytics Market - Forecasts from 2021 to 2026

出版日: | 発行: Knowledge Sourcing Intelligence | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
ヘルスケア分析市場 - 予測(2021年~2026年)
出版日: 2021年07月12日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケア分析の市場規模は、2019年の156億7,900万米ドルから、20.43%のCAGRで成長し、2026年には576億2,100万米ドルに達すると予測されています。

ヘルスケア分析は、保険金請求やその費用、医薬品の研究開発、医療記録、患者の行動や感情などに関連するヘルスケアデータの収集と分析に加え、ヘルスケアのビッグデータに見られるパターンや相関関係からインサイトを導き出し、より良いヘルスケアの意思決定に利用するプロセスが付随します。ヘルスケア分析は、データ管理にとどまらず、リアルタイムまたは過去のデータから目的を見出し、成功の確率を高めるための予測を行います。

市場を牽引している要因としては、予後を改善したいという患者の要求の高まり、医療におけるビッグデータの利用可能性とアクセスのしやすさ、医療提供を強化するための政府の取り組みの増加、さらには、医療のカスタマイズやバリューベースの医療サービスへの移行、患者数や医療記録の増加などが挙げられます。

当レポートでは、世界のヘルスケア分析市場を調査しており、市場の概要、市場の成長要因や抑制要因、タイプ別・開発モデル別・地域別などによるヘルスケア市場分析、競合状況、また主要企業のプロファイル提供しています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション

第2章 調査手法

  • 調査データ
  • 前提条件

第3章 エグゼクティブサマリー

  • 調査のハイライト

第4章 市場力学

  • 市場の推進力
  • 市場の抑制要因
  • ポーターのファイブフォース分析
    • 供給企業の取引
    • 購入企業の取引
    • 代替品の脅威
    • 新規参入業者の脅威
    • 業界における競争企業間の競争状況
  • 業界のバリューチェーン分析

第5章 タイプ別:ヘルスケア分析市場

  • イントロダクション
  • 処方的分析
  • 予測分析
  • 記述的分析

第6章 ソリューション別:ヘルスケア分析市場

  • イントロダクション
  • ハードウェア
  • ソフトウェア
  • サービス

第7章 開発モデル別のヘルスケア分析市場

  • イントロダクション
  • オンプレミス
  • クラウド

第8章 アプリケーション別:ヘルスケア分析市場

  • イントロダクション
  • 臨床データ分析
  • 財務データ分析
  • 危機管理
  • その他

第9章 エンドユーザー別:ヘルスケア分析市場

  • イントロダクション
  • ヘルスケア専門家
  • 製薬企業
  • 調査機関

第10章 地域別:ヘルスケア分析市場

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • その他
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 韓国
    • 台湾
    • タイ
    • インドネシア
    • 日本
    • その他

第11章 競合環境と分析

  • 主要企業と戦略分析
  • 新興企業と市場の収益
  • 合併、買収、合意、および共同研究
  • ベンダーの競争力マトリックス

第12章 企業プロファイル

  • IBM Corporation
  • Oracle
  • Optum Inc.
  • Crener Corporation
  • Health Catalyst
  • Geneia LLC
  • Medeanalytics
目次
Product Code: KSI061610502

The global healthcare analytics market is projected to grow at a CAGR of 20.43% to reach US$57.621 billion by 2026 from US$15.679 billion in 2019. Healthcare Analytics pertains to the collection and analysis of healthcare data relating to claims and costs, pharmaceutical research and development, medical records, and patient behavior and sentiments coupled with the process of deriving insights from patterns and correlations found in healthcare big data and used to make better healthcare decisions. Healthcare analytics extends beyond data management to finding meaning in real-time or historical data and making predictions to improve the probability of success.

Factors driving the market are growing demand for better patient outcomes, availability, and accessibility of big data in healthcare, increasing government initiatives to enhance healthcare provision, Furthermore, shifting focus towards medicine customization, value-based healthcare services, and increase in the number of patients and medical records have made healthcare analytics imperative.

Need to limit expenses and improve operational efficiencies to drive the market growth

Inclining healthcare costs attributing to a fostering arrangement of medical services benefits, the refinement of treatment, and the need to diminish expenses and improve operational efficiencies are expected to drive the market growth. As per the United States Center for Medicare and Medicaid Services, the per capita healthcare spending of the US reached $11,582 in 2019. And, National Healthcare Expenditure grew 4.6% to $3.8 trillion in 2019 and accounted for 17.7% of Gross Domestic Product.

Government policies, programs, and incentives to provide opportunities in the market

Healthcare analytics consistently incorporate various changes in the healthcare industry across the globe. Various government policies, programs, and incentives are being initiated by the governments of developed and emerging nations across the globe to enhance the experience in healthcare services. For instance, in 2016, the European Commission identified at that time 10 priority projects on Big Data implemented in Europe in a systematic review published. Additionally, the European Union had developed a project called "Bigmedilytics" in 2018 regarding the reduction of cost, better improvement of patients, and better access to the health networks. It also develops the best "Big Data technology and Healthcare policy" practices related to big data technologies, new business models, and European and national healthcare data policies and regulations.

Technological advancements and expanding interest of investors to grow market share

Additionally, the expanding amount of complex data because of the progress from paper-bound to electronic medical accounts and its capacity to improve specialists' practice will encourage the market share. Moreover, technological advancements and expanding interest of investors in healthcare analytical tools are other preferring factors that help the market propel.

  • In May 2021, Google Cloud and HCA Healthcare announced a partnership to improve data analytics and clinical decision support technologies at HCA Healthcare. The companies will operate to establish a secure and dynamic data analytics platform for HCA Healthcare, for facilitating innovative operational models on actionable insights and more productive workflows through its 32 million annual encounters to discover opportunities to enhance clinical care and support its 93,000 nurses and 47,000 active and affiliated physicians.
  • In June 2021, QPharma, a cloud-based software, and services company for life sciences announced the launch of Neolytica, a subsidiary that will take healthcare analytics to an extraordinary level focusing on platforms and solutions using next-generation technologies like NLP, AI, face recognition, and chatbots.

Insufficient skilled personnel to restrain the market growth

Notwithstanding, information stockpiling and analyzing the raw information requires an appropriately trained workforce. There is an expanding expertise gap that is going about as a hindrance to the healthcare sector. The absence of wide abilities, information, mastery, and experience needed to work in the data analytics field are critical concerns for the healthcare analytics market. As a result, the Indian government has promised to set up an institute of Big data and analytics with an aim to skilled personnel and improve public healthcare.

Geographically, North America is expected to witness the highest market growth over the projected period owing to advanced Information and Communication Technology and the presence of large IT firms, followed by Europe. In June 2021, EXL, American multinational services company involved in operations management and analytics, announced the launch of new Integrated Revenue Management Solutions from its EXL Health division. EXL Health has entered a partnership with REVELOHEALTH, a contributor of solutions aimed at converting healthcare data into actionable information.

Market Segmentation:

  • By Type

Prescriptive Analytics

Predictive Analytics

Descriptive Analytics

  • By Solution

Hardware

Software

Services

  • By Development Model

On-Premise

Cloud

  • By Application

Clinical Data Analytics

Financial Data Analytics

Risk Management

Others

  • By End-user

Healthcare Professionals

Pharmaceutical Companies

Research Organization

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Spain
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Powers of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. The threat of New Entrants
    • 4.3.5. Competitive Rivalry in Industry
  • 4.4. Industry Value Chain Analysis

5. Healthcare Analytics Market, by Type

  • 5.1. Introduction
  • 5.2. Prescriptive Analytics
  • 5.3. Predictive Analytics
  • 5.4. Descriptive Analytics

6. Healthcare Analytics Market, by Solution

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software
  • 6.4. Services

7. Healthcare Analytics Market, by Development Model

  • 7.1. Introduction
  • 7.2. On-Premise
  • 7.3. Cloud

8. Healthcare Analytics Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Data Analytics
  • 8.3. Financial Data Analytics
  • 8.4. Risk Management
  • 8.5. Others

9. Healthcare Analytics Market, by End-Users

  • 9.1. Introduction
  • 9.2. Healthcare Professionals
  • 9.3. Pharmaceutical Companies
  • 9.4. Research Organization

10. Healthcare Analytics Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. United States
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. The Middle East and Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Israel
    • 10.5.4. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. India
    • 10.6.3. South Korea
    • 10.6.4. Taiwan
    • 10.6.5. Thailand
    • 10.6.6. Indonesia
    • 10.6.7. Japan
    • 10.6.8. Others

11. Competitive Environment and Analysis

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Emerging Players and Market Lucrative
  • 11.3. Mergers, Acquisition, Agreements, and Collaborations
  • 11.4. Vendor Competitiveness Matrix

12. Company Profiles

  • 12.1. IBM Corporation
  • 12.2. Oracle
  • 12.3. Optum Inc.
  • 12.4. Crener Corporation
  • 12.5. Health Catalyst
  • 12.6. Geneia LLC
  • 12.7. Medeanalytics